{"entity":{"type":"insider","cik":"0001250316","url":"/insider/0001250316","json_url":"/insider/0001250316.json","name":"SCHEINBERG DAVID A","name_source":"as-filed","also_issuer":false,"cross_url":null},"coverage_statement":{"n_transactions":21,"n_filings":9,"first":"2003-10-03","last":"2012-02-27","span_basis":"filed_date"},"name_variants":[{"name":"SCHEINBERG DAVID A","source":"filing","n_filings":9,"first_seen":"2003-10-03","last_seen":"2012-02-27"}],"transactions":[{"id":2633100,"accession":"0001447348-12-000011","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0001447348-12-000011","line_url":"/filing/0001447348-12-000011#line-2","is_derivative":false,"issuer_cik":"0000835887","issuer_name":"PROGENICS PHARMACEUTICALS INC","issuer_ticker":"PGNX","issuer_name_source":null,"issuer_url":"/issuer/0000835887","owner_cik":"0001250316","owner_name":"SCHEINBERG DAVID A","owner_display_name":"SCHEINBERG DAVID A","owner_url":"/insider/0001250316","role":"Director","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":null,"security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":1250.0,"shares_display":"1,250","price_per_share":10.0,"price_display":"10.00","price_state":"stated","total_value":12500.0,"total_display":"12,500.00","total_whole":"12,500","shares_owned_after":46185.0,"shares_owned_after_display":"46,185","ownership_form":"D","is_10b5_1":null,"transaction_date":"2012-02-23","filed_date":"2012-02-27","scope":"insider"},{"id":7485146,"accession":"0001266375-07-000022","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0001266375-07-000022","line_url":"/filing/0001266375-07-000022#line-2","is_derivative":false,"issuer_cik":"0000835887","issuer_name":"PROGENICS PHARMACEUTICALS INC","issuer_ticker":"PGNX","issuer_name_source":null,"issuer_url":"/issuer/0000835887","owner_cik":"0001250316","owner_name":"SCHEINBERG DAVID A","owner_display_name":"SCHEINBERG DAVID A","owner_url":"/insider/0001250316","role":"Director","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":null,"security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":10000.0,"shares_display":"10,000","price_per_share":25.989,"price_display":"25.99","price_state":"stated","total_value":259890.0,"total_display":"259,890.00","total_whole":"259,890","shares_owned_after":32181.0,"shares_owned_after_display":"32,181","ownership_form":"D","is_10b5_1":null,"transaction_date":"2007-03-01","filed_date":"2007-03-02","scope":"insider"},{"id":7986063,"accession":"0001266375-07-000017","txn_seq":8,"anchor":"line-8","filing_url":"/filing/0001266375-07-000017","line_url":"/filing/0001266375-07-000017","is_derivative":false,"issuer_cik":"0000835887","issuer_name":"PROGENICS PHARMACEUTICALS INC","issuer_ticker":"PGNX","issuer_name_source":null,"issuer_url":"/issuer/0000835887","owner_cik":"0001250316","owner_name":"SCHEINBERG DAVID A","owner_display_name":"SCHEINBERG DAVID A","owner_url":"/insider/0001250316","role":"Director","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":null,"security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":30000.0,"shares_display":"30,000","price_per_share":30.105,"price_display":"30.10","price_state":"stated","total_value":903150.0,"total_display":"903,150.00","total_whole":"903,150","shares_owned_after":32181.0,"shares_owned_after_display":"32,181","ownership_form":"D","is_10b5_1":null,"transaction_date":"2007-02-02","filed_date":"2007-02-06","scope":"insider","n_lines":4},{"id":5563054,"accession":"0001266375-06-000108","txn_seq":6,"anchor":"line-6","filing_url":"/filing/0001266375-06-000108","line_url":"/filing/0001266375-06-000108","is_derivative":false,"issuer_cik":"0000835887","issuer_name":"PROGENICS PHARMACEUTICALS INC","issuer_ticker":"PGNX","issuer_name_source":null,"issuer_url":"/issuer/0000835887","owner_cik":"0001250316","owner_name":"SCHEINBERG DAVID A","owner_display_name":"SCHEINBERG DAVID A","owner_url":"/insider/0001250316","role":"Director","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":null,"security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":10000.0,"shares_display":"10,000","price_per_share":27.1487,"price_display":"27.15","price_state":"stated","total_value":271487.0,"total_display":"271,487.00","total_whole":"271,487","shares_owned_after":24181.0,"shares_owned_after_display":"24,181","ownership_form":"D","is_10b5_1":null,"transaction_date":"2006-12-01","filed_date":"2006-12-05","scope":"insider","n_lines":3},{"id":5279855,"accession":"0001266375-06-000043","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0001266375-06-000043","line_url":"/filing/0001266375-06-000043#line-2","is_derivative":false,"issuer_cik":"0000835887","issuer_name":"PROGENICS PHARMACEUTICALS INC","issuer_ticker":"PGNX","issuer_name_source":null,"issuer_url":"/issuer/0000835887","owner_cik":"0001250316","owner_name":"SCHEINBERG DAVID A","owner_display_name":"SCHEINBERG DAVID A","owner_url":"/insider/0001250316","role":"Director","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":null,"security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":5000.0,"shares_display":"5,000","price_per_share":30.02,"price_display":"30.02","price_state":"stated","total_value":150100.0,"total_display":"150,100.00","total_whole":"150,100","shares_owned_after":24181.0,"shares_owned_after_display":"24,181","ownership_form":"D","is_10b5_1":null,"transaction_date":"2006-02-27","filed_date":"2006-03-07","scope":"insider"},{"id":1242406,"accession":"0001331438-05-000016","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0001331438-05-000016","line_url":"/filing/0001331438-05-000016#line-2","is_derivative":false,"issuer_cik":"0000835887","issuer_name":"PROGENICS PHARMACEUTICALS INC","issuer_ticker":"PGNX","issuer_name_source":null,"issuer_url":"/issuer/0000835887","owner_cik":"0001250316","owner_name":"SCHEINBERG DAVID A","owner_display_name":"SCHEINBERG DAVID A","owner_url":"/insider/0001250316","role":"Director","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":null,"security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":2000.0,"shares_display":"2,000","price_per_share":20.85,"price_display":"20.85","price_state":"stated","total_value":41700.0,"total_display":"41,700.00","total_whole":"41,700","shares_owned_after":23713.0,"shares_owned_after_display":"23,713","ownership_form":"D","is_10b5_1":null,"transaction_date":"2005-07-01","filed_date":"2005-07-06","scope":"insider"},{"id":300698,"accession":"0001125282-04-006542","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0001125282-04-006542","line_url":"/filing/0001125282-04-006542#line-2","is_derivative":false,"issuer_cik":"0000835887","issuer_name":"PROGENICS PHARMACEUTICALS INC","issuer_ticker":"PGNX","issuer_name_source":null,"issuer_url":"/issuer/0000835887","owner_cik":"0001250316","owner_name":"SCHEINBERG DAVID A","owner_display_name":"SCHEINBERG DAVID A","owner_url":"/insider/0001250316","role":"Director","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":null,"security_title":"Common Stock, par value $.0013","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":4000.0,"shares_display":"4,000","price_per_share":17.0,"price_display":"17.00","price_state":"stated","total_value":68000.0,"total_display":"68,000.00","total_whole":"68,000","shares_owned_after":21963.0,"shares_owned_after_display":"21,963","ownership_form":"D","is_10b5_1":null,"transaction_date":"2004-12-22","filed_date":"2004-12-28","scope":"insider"},{"id":96839,"accession":"0001125282-03-005923","txn_seq":7,"anchor":"line-7","filing_url":"/filing/0001125282-03-005923","line_url":"/filing/0001125282-03-005923","is_derivative":false,"issuer_cik":"0000835887","issuer_name":"PROGENICS PHARMACEUTICALS INC","issuer_ticker":"PGNX","issuer_name_source":null,"issuer_url":"/issuer/0000835887","owner_cik":"0001250316","owner_name":"SCHEINBERG DAVID A","owner_display_name":"SCHEINBERG DAVID A","owner_url":"/insider/0001250316","role":"Director","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":null,"security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":4000.0,"shares_display":"4,000","price_per_share":16.65,"price_display":"16.65","price_state":"stated","total_value":66600.0,"total_display":"66,600.00","total_whole":"66,600","shares_owned_after":0.0,"shares_owned_after_display":"0","ownership_form":"D","is_10b5_1":null,"transaction_date":"2003-11-05","filed_date":"2003-11-05","scope":"insider","n_lines":2},{"id":96836,"accession":"0001125282-03-005923","txn_seq":4,"anchor":"line-4","filing_url":"/filing/0001125282-03-005923","line_url":"/filing/0001125282-03-005923#line-4","is_derivative":false,"issuer_cik":"0000835887","issuer_name":"PROGENICS PHARMACEUTICALS INC","issuer_ticker":"PGNX","issuer_name_source":null,"issuer_url":"/issuer/0000835887","owner_cik":"0001250316","owner_name":"SCHEINBERG DAVID A","owner_display_name":"SCHEINBERG DAVID A","owner_url":"/insider/0001250316","role":"Director","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":null,"security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":2000.0,"shares_display":"2,000","price_per_share":17.7,"price_display":"17.70","price_state":"stated","total_value":35400.0,"total_display":"35,400.00","total_whole":"35,400","shares_owned_after":0.0,"shares_owned_after_display":"0","ownership_form":"D","is_10b5_1":null,"transaction_date":"2003-11-04","filed_date":"2003-11-05","scope":"insider"},{"id":96833,"accession":"0001125282-03-005923","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001125282-03-005923","line_url":"/filing/0001125282-03-005923#line-1","is_derivative":false,"issuer_cik":"0000835887","issuer_name":"PROGENICS PHARMACEUTICALS INC","issuer_ticker":"PGNX","issuer_name_source":null,"issuer_url":"/issuer/0000835887","owner_cik":"0001250316","owner_name":"SCHEINBERG DAVID A","owner_display_name":"SCHEINBERG DAVID A","owner_url":"/insider/0001250316","role":"Director","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":null,"security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":4000.0,"shares_display":"4,000","price_per_share":18.0,"price_display":"18.00","price_state":"stated","total_value":72000.0,"total_display":"72,000.00","total_whole":"72,000","shares_owned_after":0.0,"shares_owned_after_display":"0","ownership_form":"D","is_10b5_1":null,"transaction_date":"2003-11-03","filed_date":"2003-11-05","scope":"insider"},{"id":88082,"accession":"0001125282-03-005526","txn_seq":8,"anchor":"line-8","filing_url":"/filing/0001125282-03-005526","line_url":"/filing/0001125282-03-005526","is_derivative":false,"issuer_cik":"0000835887","issuer_name":"PROGENICS PHARMACEUTICALS INC","issuer_ticker":"PGNX","issuer_name_source":null,"issuer_url":"/issuer/0000835887","owner_cik":"0001250316","owner_name":"SCHEINBERG DAVID A","owner_display_name":"SCHEINBERG DAVID A","owner_url":"/insider/0001250316","role":"Director","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":null,"security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":10000.0,"shares_display":"10,000","price_per_share":16.8818,"price_display":"16.88","price_state":"stated","total_value":168818.0,"total_display":"168,818.00","total_whole":"168,818","shares_owned_after":1.0,"shares_owned_after_display":"1","ownership_form":"D","is_10b5_1":null,"transaction_date":"2003-10-01","filed_date":"2003-10-03","scope":"insider","n_lines":4},{"id":88075,"accession":"0001125282-03-005526","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001125282-03-005526","line_url":"/filing/0001125282-03-005526#line-1","is_derivative":false,"issuer_cik":"0000835887","issuer_name":"PROGENICS PHARMACEUTICALS INC","issuer_ticker":"PGNX","issuer_name_source":null,"issuer_url":"/issuer/0000835887","owner_cik":"0001250316","owner_name":"SCHEINBERG DAVID A","owner_display_name":"SCHEINBERG DAVID A","owner_url":"/insider/0001250316","role":"Director","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":null,"security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":30000.0,"shares_display":"30,000","price_per_share":19.986,"price_display":"19.99","price_state":"stated","total_value":599580.0,"total_display":"599,580.00","total_whole":"599,580","shares_owned_after":1.0,"shares_owned_after_display":"1","ownership_form":"D","is_10b5_1":null,"transaction_date":"2003-09-24","filed_date":"2003-10-03","scope":"insider"}],"collapsed":true,"next_cursor":null,"ledger_fault":false,"count":{"value":21,"kind":"exact"},"open_market_only":false,"composition":{"kind":"exact","rows":[{"code":"P","label":"Open-market purchase","n":0,"open_market":true},{"code":"S","label":"Open-market sale","n":21,"open_market":true},{"code":"M","label":"Option exercise","n":0,"open_market":false},{"code":"A","label":"Grant or award","n":0,"open_market":false},{"code":"F","label":"Tax withholding","n":0,"open_market":false},{"code":"D","label":"Disposition to the issuer","n":0,"open_market":false},{"code":"X","label":"In-the-money option exercise","n":0,"open_market":false}],"total":21},"affiliations":[{"type":"issuer","type_label":"ISSUER","cik":"0000835887","name":"PROGENICS PHARMACEUTICALS INC","url":"/issuer/0000835887","role":"Director","n_filings":9,"first_seen":"2003-10-03","last_seen":"2012-02-27"}],"order_statement":"Newest transaction date first, id breaking the tie.","canonical_url":"https://ebomi.com/insider/0001250316","retrieved_at":"2026-08-23T09:06:36+00:00","coverage":{"filings":1506293,"transactions":4290787,"issuers":28597,"insiders":152303,"first_filed_date":"2003-06-30","last_filed_date":"2026-08-21","last_ingest":"2026-08-22T05:23:40.159918+00:00","counts_are":{"filings":"estimate","transactions":"estimate","issuers":"estimate","insiders":"estimate"},"source":"SEC EDGAR Form 4 filings, parsed by ebomi","fault":false},"license":{"underlying_records":"US SEC filings are public records of the United States government and are not subject to copyright. The transactional facts in them are not ours to license.","this_presentation":"The parsing, normalisation, curation, and presentation are ebomi's own work.","grant":"undecided","grant_note":"The open licence for ebomi's own layer is an open owner decision (SPEC-20260731T1159Z open question 3: CC BY 4.0 or CC0 with a citation request). Until it is taken, no grant is asserted here.","citation_request":"Balogh, A. Insider trading. Scientific Data 10, 237 (2023)","url":"https://ebomi.com/license"},"fair_use":{"policy":"These JSON endpoints are open and unauthenticated. Please read them at a human pace, identify your client in the User-Agent header, and use the published dataset for bulk work rather than crawling page by page.","bulk_alternative":"doi:10.1038/s41597-023-02147-6"}}